The next generation of personalized oncology in the US
Oct 15, 2014
Listen to Laura Housman, Chief Commercial Officera at Molecular Health, and Stan Skrzypczak, Vice President of Business Development at InVitae, share their years of experience in the field to deliver a roadmap to the reimbursement landscape for advanced next-generation sequencing in oncology, and explain how to guarantee that your diagnostic tests evolve with and ahead of dynamic clinical advances
Please login to view video - or subscribe here
This content is premium content, and only accessible to Premium members. Get On Demand now